Results for tag: Dana-Farber Cancer Institute Total Items Found: 61

Ann Partridge and Véronique Dieras on the Future of Cytotoxic Therapy Antibody-Drug Conjugates

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute

Created: 6/16/2022 9:20:59 PM

Ann Partridge and Ian Krop on Metastatic Breast Cancer New Early Data on Patritumab Deruxtecan

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Yale Cancer Center

Created: 6/16/2022 9:06:44 PM

Ann Partridge and Kevin Kalinsky on Breast Cancer Latest Findings on Fulvestrant or Exemestane With or Without Ribociclib

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Winship Cancer Institute
Emory University

Created: 6/13/2022 8:25:35 PM

Ursula Matulonis and Domenica Lorusso on Gynecologic Cancers New Findings on Trabectedin vs Clinician’s Choice Chemotherapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
Gemelli University Hospital
Dana-Farber Cancer Institute

Created: 6/13/2022 8:18:11 PM

Alicia Morgans and Michael Hofman on Prostate Cancer New Data on LuPSMA vs Cabazitaxel

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Peter MacCallum Cancer Centre

Created: 6/8/2022 8:14:25 PM

Alicia Morgans and Ian Davis on Prostate Cancer Updated Overall Survival Outcomes With Enzalutamide

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Monash University

Created: 6/8/2022 8:00:41 PM

Ursula Matulonis and Ignace Vergote on Cervical Cancer Interim Results on Tisotumab Vedotin-tftv Plus Pembrolizumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
University Hospitals Leuven

Created: 6/8/2022 7:43:52 PM

Ursula A. Matulonis and Nicoletta Colombo on Ovarian Cancer Overall Survival Data on Relacorilant Plus Nab-Paclitaxel

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
University of Milan
European Institute of Oncology

Created: 6/6/2022 7:54:34 PM

Dana Farber

Type of Page:institutionalHighlights
Edit This Item
Tags for this item:

Created: 5/26/2022 1:41:29 PM

Matthew Meyerson on Lung Adenocarcinoma Somatic Mutations, Germline Risk, and Ancestry

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute

Created: 5/18/2022 6:35:51 PM

Ursula Matulonis on Ovarian Cancer New Data on Mirvetuximab Soravtansine

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute

Created: 5/16/2022 5:24:21 PM

Julia Rotow on Patient Selection in Treating Thoracic Cancers Looking to Driver Mutations and Biomarkers

Type of Page:TapVideo
Edit This Item
Tags for this item:
lung cancer
genomics
genetics
Dana-Farber Cancer Institute

Created: 1/26/2022 7:53:12 PM

Matthew S. Davids, MD, on Younger Patients With CLL: Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
leukemia
Dana-Farber Cancer Institute

Created: 1/25/2022 10:05:27 PM

Elizabeth Mittendorf on Making Strides in Managing Triple-Negative Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
breast cancer
immunotherapy
Dana-Farber Cancer Institute

Created: 1/12/2022 7:35:08 PM

Romanos Sklavenitis-Pistofidis on Smoldering Myeloma Identifying Biomarkers of Response to Immunotherapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
multiple myeloma
immunotherapy
Dana-Farber Cancer Institute

Created: 1/11/2022 4:51:47 PM

Anil Aktas-Samur on Identifying Low-Risk Smoldering Multiple Myeloma

Type of Page:TapVideo
Edit This Item
Tags for this item:
multiple myeloma
genetics
genomics
Dana-Farber Cancer Institute

Created: 1/11/2022 4:48:56 PM

Nikhil Munshi on COVID-19 Vaccine Effectiveness in Patients With Multiple Myeloma

Type of Page:TapVideo
Edit This Item
Tags for this item:
multiple myeloma
COVID-19
Dana-Farber Cancer Institute

Created: 1/3/2022 7:27:41 PM

Diana Shi on IDH-Mutant Gliomas De Novo Pyrmidine Synthesis Inhibitor Under Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Brigham and Women's Cancer Center
CNS cancer
glioma

Created: 10/26/2021 6:50:06 PM

Toni Choueiri on Renal Cell Carcinoma Quality-of-Life Data From KEYNOTE-564 on Pembrolizumab vs Placebo

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
kidney cancer

Created: 9/20/2021 6:06:26 PM

Paul Richardson on Multiple Myeloma and COVID-19 An Update

Type of Page:TapVideo
Edit This Item
Tags for this item:
multiple myeloma
COVID-19
Dana-Farber Cancer Institute

Created: 7/14/2021 7:12:44 PM

Ann LaCasce on Hodgkin Lymphoma PET-Adapted Therapy for Bulky Disease

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
lymphoma

Created: 6/15/2021 9:35:16 PM

Pasi Janne on NSCLC Patritumab Deruxtecan to Target HER3

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
lung cancer

Created: 6/4/2021 7:46:39 PM

Toni Choueiri on Renal Cell Carcinoma Pembrolizumab vs Placebo in Adjuvant Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
kidney cancer

Created: 6/4/2021 4:51:51 PM

Paul Richardson and Peter Voorhees on Multiple Myeloma Surveying the Evolving Landscape of Up-Front Drugs

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Levine Cancer Institute

Created: 4/27/2021 3:51:59 PM

Jennifer Brown on Managing Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute

Created: 4/7/2021 6:37:02 PM

Deborah Schrag Cancer Health Justice Disparities

Type of Page:TapVideo
Edit This Item
Tags for this item:
Yale Law
cancer
health justice
health care disparities
Dana-Farber Cancer Institute
Harvard Medical School

Created: 4/19/2018 3:19:12 PM

Ed Benz The Business of Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
Yale Law
business
health-care
cancer
Dana-Farber Cancer Institute

Created: 4/19/2018 3:00:31 PM

Sharyn L. Kurtz, PA-C, MPAS, MA, on Managing Lymphoma Survivors

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN Hematologic Malignancies
Sharyn Kurtz
Dana-Farber Cancer Institute
cancer survivor
lymphoma
survivorship
Hodgkin lymphoma
non-Hodgkin lymphoma
long-term side effects

Created: 10/11/2017 4:13:40 PM

Judy E. Garber, MD, MPH, on Triple-Negative Breast Cancer: An Update

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2017
Judy Garber
Dana-Farber Cancer Institute
triple-negative breast cancer
TNBC
PARP inhibitors

Created: 9/12/2017 11:16:49 AM

Robert I. Haddad, MD, on Head and Neck Cancer: Results of the CheckMate 141 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2017
Robert Haddad
Dana-Farber Cancer Institute
head and neck cancer
CheckMate 141
nivolumab
squamous cell carcinoma
HNSCC

Created: 9/11/2017 3:42:43 AM

Toni K. Choueiri, MD, and Sumanta K. Pal, MD, on Top Kidney Cancer Abstracts: Expert Perspectives

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Sumanta Pal
City of Hope
Toni Choueiri
Dana-Farber Cancer Institute
renal cell carcinoma
kidney cancer

Created: 6/5/2017 2:48:11 PM

Temidayo Fadelu, MD, on Colon Cancer: Results From the CALGB 89803 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Temidayo Fadelu
Dana-Farber Cancer Institute
colon cancer
CALGB 89803
nut consumption
tree nuts
cancer recurrence
risk of death

Created: 6/4/2017 1:06:15 PM

Soft-Tissue Sarcoma: Evolving Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
Suzanne George
Dana-Farber Cancer Institute
soft-tissue sarcoma
NCCN 22nd Annual Conference

Created: 3/24/2017 9:40:49 AM

Paul L. Nguyen, MD, on Prostate Cancer: Active Surveillance

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Cancers Symposium 2017
Paul Nguyen
Dana-Farber Cancer Institute
prostate cancer
active surveillance
prostate cancer guidelines
ProtecT
genomic test
hereditary test

Created: 2/21/2017 3:17:47 PM

Paul L. Nguyen, MD, on Predicting Metastasis and Mortality

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Cancers Symposium 2017
Paul Nguyen
Dana-Farber Cancer Institute
Decipher prostate cancer classif
metastasis
mortality
genomic analysis
needle biopsy

Created: 2/21/2017 3:13:05 PM

Shoshana M. Rosenberg, ScD, MPH, on Young Breast Cancer Survivors: Helping Them Cope

Type of Page:TapVideo
Edit This Item
Tags for this item:
Cancer Survivorship Symposium
Shoshana Rosenberg
Dana-Farber Cancer Institute
breast cancer survivors
young breast cancer
survivorship
active treatment
focus group
physical experience
psychological experience

Created: 1/31/2017 2:00:50 PM

Ann H. Partridge, MD, MPH, on Adolescent and Young Adult Patients: Their Survivorship Challenges

Type of Page:TapVideo
Edit This Item
Tags for this item:
Cancer Survivorship Symposium
Ann Partridge
Dana-Farber Cancer Institute
adolescent cancer
young adult cancer
AYA cancer
AYA survivors
psychosocial

Created: 1/31/2017 12:02:21 PM

Brendan J. Guercio, MD, on Colorectal Cancer and Physical Activity: Impact on Survival

Type of Page:TapVideo
Edit This Item
Tags for this item:
GI Cancers Symposium 2017
Brendan Guercio
Dana-Farber Cancer Institute
colorectal cancer
physical activity
disease progression
overall survival

Created: 1/23/2017 2:03:51 PM

Eric P. Winer, MD: The McGuire Lecture

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast
Eric Winer
Dana-Farber Cancer Institute

Created: 12/9/2016 5:05:59 PM

Nikhil Wagle, MD, on Breast Cancer: Advances in Genomics

Type of Page:TapVideo
Edit This Item
Tags for this item:
Nikhil Wagle
Dana-Farber Cancer Institute
genomics
breast cancer
genomic sequencing
ER+ metastatic
treatment resistant
next therapy
clinical trial eligibility
novel drug targets
San Antonio Breast

Created: 12/9/2016 3:20:18 PM

Ruth O’Regan, MD, and Ann H. Partridge, MD, on The NRG Oncology/NSABP B-42, IDEAL, and DATA Studies

Type of Page:TapVideo
Edit This Item
Tags for this item:
Ruth O'Regan
University of Wisconsin
Ann Partridge
Dana-Farber Cancer Institute
NRG Oncology/NSABP B-42 trial
IDEAL trial
DATA trial
anastrozole
tamoxifen
letrozole
adjuvant endocrine therapy
HR-positive breast cancer
San Antonio Breast

Created: 12/9/2016 12:04:33 PM

Harold J. Burstein, MD, PhD, on Adjuvant Endocrine Therapy: Expert Perspective

Type of Page:TapVideo
Edit This Item
Tags for this item:
Harold Burstein
Dana-Farber Cancer Institute
adjuvant endocrine therapy
breast cancer
San Antonio Breast

Created: 12/9/2016 10:48:33 AM

Ruth O’Regan, MD, and Ann H. Partridge, MD, on HER2+ Breast Cancer: Results From the CLEOPATRA Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
Ruth O'Regan
University of Wisconsin
Ann Partridge
Dana-Farber Cancer Institute
HER2+ breast cancer
breast cancer
CLEOPATRA trial
TILs
San Antonio Breast

Created: 12/9/2016 10:27:12 AM

Stephen R.D. Johnston, MBBS, PhD, and Ann H. Partridge, MD, on Breast Cancer: Managing Metastatic ER+ Disease

Type of Page:TapVideo
Edit This Item
Tags for this item:
The Royal Marsden NHS Foundation
Ann Partridge
Dana-Farber Cancer Institute
endocrine therapy
optimal sequencing
first-line treatment
resistance pathways
second-line treatment
breast cancer
Stephen R.D. Johnston
ER+ breast cancer
San Antonio Breast
estrogen receptor-positive
Stephen Johnston

Created: 12/8/2016 4:40:27 PM

Jennifer K. Litton, MD, and Ann H. Partridge, MD, on Breast Cancer in Young Women

Type of Page:TapVideo
Edit This Item
Tags for this item:
Jennifer Litton
Ann Partridge
Dana-Farber Cancer Institute
MD Anderson Cancer Center
breast cancer in young women
epidemiology in younger patients
biology in younger patients
fertility
pregnancy
San Antonio Breast

Created: 12/8/2016 4:33:26 PM

Toni K. Choueiri, MD, on Metastatic RCC: Results From the ALLIANCE A031203 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Toni Choueiri
Dana-Farber Cancer Institute
renal cell carcinoma
kidney cancer
ALLIANCE A031203 trial

Created: 10/10/2016 7:36:57 AM

Paul L. Nguyen, MD, on Prostate Cancer: High-Risk Disease, Brachytherapy, And Hormones

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 ASTRO Annual Meeting
Paul Nguyen
Dana-Farber Cancer Institute
prostate cancer
high-risk prostate cancer
brachytherapy
hormone treatment
PSA
local recurrence
androgen deprivation
high-dose radiotherapy

Created: 9/28/2016 11:03:02 AM

Stephen T. Sonis, DMD, DMSc, on Radiotherapy-Induced Oral Complications

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 Palliative Care in Oncology
Stephen Sonis
Dana-Farber Cancer Institute
radiotherapy oral complications
radiotherapy
mucositis
osteoradionecrosis
toxicity
head and neck
radiation
dry mouth
fibrosis
salivary glands
periodontal disease
genomics
cost of care

Created: 9/12/2016 11:30:19 AM

Tracy A. Balboni, MD, MPH, on Managing Spinal Metastases With Radiation Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 Palliative Care in Oncology
Tracy Balboni
Dana-Farber Cancer Institute
radiation therapy
spinal metastases
quality of life
spinal lesions
spinal instability
cancer metastases
palliative care

Created: 9/12/2016 10:20:45 AM

Sagar Lonial, MD, and Paul G. Richardson, MD, on Multiple Myeloma: Expert Perspectives on Treatment Advances

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Sagar Lonial
Dana-Farber Cancer Institute
Paul Richardson
multiple myeloma

Created: 6/9/2016 2:52:01 PM

Helen MacKay, MD, and Ursula A. Matulonis, MD, on Epithelial Ovarian Cancer: Results From the OV21-PETROC Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
Dana-Farber Cancer Institute
Princess Margaret Cancer Centre
Ursula Matulonis
Helen MacKay
ASCO 2016
intraperitoneal chemotherapy
epithelial ovarian cancer
neoadjuvant chemotherapy
intravenous chemotherapy
ovarian cancer
debulking surgery

Created: 6/8/2016 10:44:43 AM

Toni K. Choueiri, MD, and David F. McDermott, MD, on Advanced RCC: Nivolumab in Previously Treated Patients

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Beth Israel Deaconess
Dana-Farber Cancer Institute
David McDermott
Toni Choueiri
renal cell carcinoma
kidney cancer
long-term overall survival
nivolumab

Created: 6/8/2016 9:52:48 AM

Kenneth Anderson, MD, on Multiple Myeloma Guideline Updates

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 NCCN Annual Meeting
Kenneth Anderson
Dana-Farber Cancer Institute
multiple myeloma

Created: 4/4/2016 2:40:34 PM

Joseph O. Jacobson, MD, on Improving Cancer Care: What Works, What Doesn’t, and Why

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 Quality Care Symposium
Joseph Jacobson
Dana-Farber Cancer Institute
improving cancer care

Created: 2/29/2016 11:42:57 AM

Gregory T. Armstrong, MD, MSCE, and Lisa Diller, MD, on Reduction of Late Mortality in Childhood Cancer Survivors

Type of Page:TapVideo
Edit This Item
Tags for this item:
Gregory Armstrong
St. Jude Children's Research Hos
Lisa Diller
Dana-Farber Cancer Institute
ASCO
childhood cancer
survivor
recurrence
progress
late effects
Wilms tumor
neuroblastoma
ASCO 2015

Created: 1/31/2016 9:02:09 AM

Lori Wiener, PhD, DCSW, LCSW-C, and Karen Fasciano, PsyD, on Psycho-Oncology: Where the Field Is Headed

Type of Page:TapVideo
Edit This Item
Tags for this item:
IPOS-APOS 2015
Lori Wiener
National Cancer Institute
Karen Fasciano
Dana-Farber Cancer Institute
distress
quality of life survivor
integrated care
psychosocial care

Created: 1/31/2016 12:57:51 AM

Judith Vick, MD Candidate, and Rachelle E. Bernacki, MD, on A New Clinical Tool: The “Surprise Question”

Type of Page:TapVideo
Edit This Item
Tags for this item:
2015 Palliative Care in Oncology
Judith Vick
Rachelle Bernacki
Johns Hopkins Medicine
Dana-Farber Cancer Institute
surprise conversation
high risk of dying
hopes
fears
improved quality of life

Created: 1/31/2016 12:28:22 AM

Christopher J. Sweeney, MBBS: Testicular Cancer Update

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Symposium 2016
Christopher Sweeney
Dana-Farber Cancer Institute
testicular cancer
first-line therapy
metastatic cancer
genetics
biomarkers

Created: 1/31/2016 12:06:31 AM

Paul L. Nguyen, MD, on Prostate Cancer: Results of the NRG Oncology/RTOG 9601 Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Symposium 2016
Paul Nguyen
Dana-Farber Cancer Institute
prostate cancer
NRG Oncology
RTOG 9601
antiandrogen therapy
bicalutamide
salvage radiation therapy
prostatectomy
PSA
prostate-specific antigen

Created: 1/31/2016 12:04:37 AM

Toni Choueiri, MD: Renal Cancer Update

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Symposium 2016
Toni Choueiri
Dana-Farber Cancer Institute
clear cell renal cancer
non-clear cell renal cancer
renal cancer
genetics
treatment update

Created: 1/31/2016 12:02:36 AM

Harold J. Burstein, MD, PhD, on Results of the CREATE-X Clinical Trial on Higher-Risk Disease

Type of Page:TapVideo
Edit This Item
Tags for this item:
SABCS 2015
Harold Burstein
Dana-Farber Cancer Institute
CREATE-X clinical trial
breast cancer
high-risk breast cancer
capecitabine
residual disease

Created: 12/24/2015 12:26:04 PM
Order By Item Count
Order Alphabetically